Selected article for: "hepatitis virus and RNA virus"

Author: Malboeuf, Christine M.; Yang, Xiao; Charlebois, Patrick; Qu, James; Berlin, Aaron M.; Casali, Monica; Pesko, Kendra N.; Boutwell, Christian L.; DeVincenzo, John P.; Ebel, Gregory D.; Allen, Todd M.; Zody, Michael C.; Henn, Matthew R.; Levin, Joshua Z.
Title: Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification
  • Document date: 2012_9_8
  • ID: s76c5ebd_3
    Snippet: Sequence-independent methods (21) (22) (23) (24) (25) are attractive for sequencing viral genomes in that they do not rely on prior viral sequence knowledge. This allows sequencing of viral genomes with little or no genomic information and of highly divergent viruses for which robust primers targeting conserved regions are difficult to design. To date these methods have difficulty with sequencing complete genomes from clinical samples due to high.....
    Document: Sequence-independent methods (21) (22) (23) (24) (25) are attractive for sequencing viral genomes in that they do not rely on prior viral sequence knowledge. This allows sequencing of viral genomes with little or no genomic information and of highly divergent viruses for which robust primers targeting conserved regions are difficult to design. To date these methods have difficulty with sequencing complete genomes from clinical samples due to high levels of host contamination and low viral amounts. The SISPA method described by Djikeng et al. is capable of capturing complete genomes from viral RNA samples, but requires high viral amounts and removal of host RNA contamination with RNases prior to viral RNA extraction (22) . Work by Victoria et al. demonstrated the ability to capture complete genomes from stool samples, but it appears these samples had high viral titers (25) . Recent work by Ninomiya et al. has demonstrated success of capturing hepatitis C virus (HCV) total RNA sequencing from clinical samples (23) , but this method required 200 ng of input RNA which exceeds the amount typically present in most clinical samples. Moore et al. evaluated the sensitivity of detection of infectious agents using RNA sequencing (24) . Their method worked well for detecting low amounts of virus but was limited to input amounts of 30,000 copies of viral RNA per sample.

    Search related documents:
    Co phrase search for related documents
    • clinical sample and complete genome sequence: 1, 2
    • clinical sample and high level: 1, 2, 3, 4, 5, 6
    • clinical sample and high viral titer: 1, 2
    • clinical sample and host contamination: 1
    • clinical sample and host rna: 1, 2, 3, 4
    • clinical sample complete genome sequence and complete genome: 1, 2
    • clinical sample complete genome sequence and complete genome sequence: 1, 2
    • complete genome and genomic information: 1, 2, 3, 4, 5
    • complete genome and high level: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • complete genome and high viral titer: 1, 2
    • complete genome and highly divergent virus: 1, 2, 3, 4
    • complete genome and host contamination: 1
    • complete genome and host rna: 1, 2, 3, 4, 5
    • complete genome and infectious agent: 1, 2, 3, 4, 5, 6
    • complete genome sequence and genomic information: 1
    • complete genome sequence and high level: 1, 2
    • complete genome sequence and host rna: 1, 2, 3
    • complete genome sequence and infectious agent: 1, 2, 3, 4, 5
    • conserve region and high level: 1